Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
about
Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature reviewPrevalence and clinical features associated with bipolar disorder polypharmacy: a systematic reviewPrevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatmentA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyExtracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.Diffusion of antipsychotics in the US And French markets, 1998-2008Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.Antipsychotic polypharmacy in a regional health service: a population-based study.Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients.Validation of a claims-based antipsychotic polypharmacy measurePrevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practicePredictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient HospitalsGender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project.Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital.The prescribing pattern of a new antipsychotic: a descriptive study of aripiprazole for psychiatric in-patients.Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines.Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
P2860
Q24598636-2CAF1439-936C-4EED-AB37-B09885F7358EQ26751363-C1F57348-54E6-4630-845D-8AA4248243FEQ27028197-A4C24227-D5C3-41F8-B52A-141695743713Q30485065-70465BB3-F5CF-4C6A-A318-798CA5C2BA0DQ30981989-EC289F62-E0C9-4001-A2FB-12DB3EED2FDFQ33915286-6961D780-CB0D-42CB-957D-C9755FA1B956Q34194447-00DA84BF-CB61-4178-AA4E-95BCBBFA3A78Q34269517-6A27BC86-0BEC-401D-A9E7-75473B9B9EC5Q35163507-F9E5E849-7AB7-4C82-B752-12617288A8D1Q35801221-21941A61-55F7-4C94-8FB6-F4DAAA73F7DCQ36057820-4F8C0D58-FE11-48F0-BF33-1556139E1DEBQ37029622-10D378AD-E5B3-4522-BD48-7E577D43CE1EQ37042072-C4F9CF3E-B757-4487-8CA4-333E267ED33FQ37116547-17C62344-BF55-4C81-BD49-528F869A43B7Q38766834-D0097D48-B235-4A54-891D-CC3A7C4563B3Q41682303-900850DD-F8B7-49A9-9494-65CE383737D7Q44243570-F258B815-1B67-4233-86B0-8C6611BFC28DQ44897335-7F718DCF-1B00-4BA7-9C4A-4070A97F9B56Q46721830-8E359DDA-392D-4F73-9F82-5A3594DF5CB0Q48321579-DD6AA1C7-C639-4611-BF95-17698D3DDB8CQ50804521-D9EA2560-8AFA-4606-B5E0-00D3801DEC29
P2860
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@ast
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@en
type
label
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@ast
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@en
prefLabel
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@ast
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@en
P2093
P1476
Prevalence, utilization patter ...... edicaid population, 1998-2003.
@en
P2093
Dean G Haxby
Elaine H Morrato
Gary Oderda
Richard Allen
Robert J Valuck
Sheri Dodd
P304
P356
10.1016/J.CLINTHERA.2007.01.002
P577
2007-01-01T00:00:00Z